Cipla and Glenmark issue recalls in the US drug market | Republic World
Advertisement

Published 11:31 IST, May 5th 2024

Cipla and Glenmark issue recalls in the US drug market

The recall, classified as Class II by the US Food and Drug Administration, following complaints regarding the fill volume and liquid observed in the packaging.

Reported by: Business Desk
Follow: Google News Icon
  • share
Medicines
Cipla and Glenmark issue recalls in the US drug market | Image: Pexels
  • Listen to this article
  • 2 min read

11:31 IST, May 5th 2024

Advertisement